Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FES PET/CT Imaging in Endocrine Refractory Metastatic Breast Cancer
NCT02409316Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Oct 2015
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoroestradiol f 18 in breast cancer, sponsored by University of Pennsylvania. Started Oct 2015; status: terminated.
02
Drugs
fluoroestradiol f 18
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02409316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409316.